Telehealth · NJ
New Jersey.
Licensed by the New Jersey State Board of Medical Examiners
New Jersey residents can now access GLP-1 medications like semaglutide and tirzepatide through telehealth — without crossing the Hudson, scheduling weeks out at a Bergen or Essex County clinic, or fighting with insurance. Pallas Health pairs you with a board-certified provider licensed in New Jersey who reviews your intake — by secure message in most cases — and if appropriate sends a prescription to a compounding pharmacy that ships to any New Jersey address in a few business days.
Telehealth
Async + video
Asynchronous review permitted
Compounded sema
Available
Compounded tirz
Available
Shipping
2–3 business days
To any New Jersey address
Regulatory
How telehealth prescribing works in New Jersey
New Jersey permits licensed providers to establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s through telehealth — including asynchronous review of your intake — when the standard of care is met, under the New Jersey Telemedicine and Telehealth Act.
New Jersey requires any provider prescribing to a New Jersey resident to hold an active New Jersey medical license. Under the New Jersey Telemedicine and Telehealth Act (P.L. 2017, c. 117) and State Board of Medical Examiners regulations, a licensed provider may establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s through telehealth, including synchronous video and, in appropriate cases, asynchronous review, provided the standard of care is met. Every Pallas provider who treats New Jersey patients holds an active New Jersey medical license; depending on your history, a provider may follow up by message, video, or request additional labs before prescribing. GLP-1s are not controlled substances, so New Jersey's separate NJPMP and controlled-substance telemedicine requirements don't add friction here, but our providers still document a complete history, screen for contraindications like personal or family history of medullary thyroid carcinoma, and schedule follow-up visits to monitor response and titrate the dose.
Insurance
Medicaid & insurance in New Jersey
Limited coverage
NJ FamilyCare (New Jersey Medicaid) covers GLP-1s for type 2 diabetes with prior authorization. Coverage for weight-management indications is limited. Compounded GLP-1s are not covered.
Pallas is a cash-pay telehealth service. Medicaid and private insurance do not apply to our prescriptions; pricing is flat and disclosed up front.
Coverage
Cities served in New Jersey
We ship to every ZIP code in New Jersey, including:
- Newark
- Jersey City
- Paterson
- Elizabeth
- Edison
- Lakewood
- Toms River
- Trenton
FAQ
New Jersey GLP-1 questions
Usually no. The New Jersey Telemedicine and Telehealth Act allows a licensed provider to establish the provider-patient relationship and prescribe non-controlled medications like semaglutide through telehealth, including asynchronous review of your intake. Most New Jersey patients complete everything by secure message; a provider may request a brief video visit only if your history calls for it.
NJ FamilyCare covers certain GLP-1s for FDA-approved diabetes indications with prior authorization. Coverage for weight-management indications is limited. Compounded GLP-1s are not covered. Pallas is a cash-pay telehealth service, so Medicaid rules do not govern our pricing.
No. Under State Board of Medical Examiners rules, the prescribing provider must hold an active New Jersey medical license when treating a patient located in New Jersey. Every Pallas clinician who treats New Jersey patients is individually licensed in New Jersey.
Yes. Compounded semaglutide prescribed by a New Jersey-licensed provider and dispensed by a licensed compounding pharmacy is legal when prepared for a specific patient with a documented clinical need. Pallas works only with U.S. state-licensed 503A and 503B compounding pharmacies.
Start your New Jersey intake